OklahomaHB 1576Oklahoma 2026 Regular SessionHouseWALLET

Medicaid; terms; Oklahoma Health Care Authority; coverage; Medicaid; criteria; medical necessity; discretion; Chief Operating Officer; Health Information Portability and Accountability Act; scientific research; consent; research; opting-out; minors; promulgation of rules and regulations; waiver application; effective date; emergency.

Sponsored By: Mark Lawson (Republican)

Became Law

Senate Committee

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Rapid genetic testing for young Medicaid patients

The law requires Oklahoma Medicaid to pay separately for rapid whole genome sequencing, subject to required federal approval. Patients must be under 21 and receiving care in intensive care or another high-acuity hospital unit. They must have a complex or acute illness of unknown cause. The illness cannot be confirmed as caused by environmental exposure, toxic ingestion, trauma, or an infection responding normally to treatment. Testing examines the entire genome, including coding regions, non-coding regions, and mitochondrial DNA. It includes patient-only testing or testing with one or both biological parents. Preliminary positive results must return within seven days after the lab receives the sample; final results within 15–21 days. Coverage may use evidence-based medical-need rules. These require multiple possible diagnoses that otherwise call for multiple genetic tests, plus a provider finding that quick diagnosis is needed and may guide care. They also require at least one listed medical sign. Signs include birth defects affecting two organ systems, complex defects in one system, or organ defects strongly suggesting a genetic cause. Other signs include lab findings suggesting genetic or metabolic disease; severe or treatment-resistant low or high blood sugar; unusual treatment response; severe muscle weakness, rigidity, or spasticity; or treatment-resistant seizures. Certain high-risk brief resolved unexplained events, heart test findings, imaging or body-function tests suggesting genetic disease, and related family genetic history also qualify. The state's Chief Operating Officer can expand qualifying conditions or covered genetic tests based on new medical evidence. That officer must implement coverage, including needed rules, federal waiver requests or amendments, and other administrative steps. Section 2 lists July 1, 2025, as the effective date; the emergency clause also states effect upon passage and approval.

Medicaid patients control genetic data use

Genetic data from covered rapid whole genome sequencing must mainly help the ordering clinician and care team diagnose and treat the patient. The data is protected health information under HIPAA, the HITECH Act, and related privacy rules. Research use requires express consent from the patient or a minor's legal guardian. Patients or guardians can withdraw consent at any time. After written withdrawal, the provider or other entity using the data must stop using it and delete it from every repository. Patients and guardians can access results for use in other care settings; providers can access them with consent. A provider may charge a small fee based on the direct cost of preparing results in a usable format.

Sponsors & Cosponsors

Sponsor

  • Mark Lawson

    Republican • House

Cosponsors

  • Josh Cantrell

    Republican • House

  • Carri Hicks

    Democratic • Senate

  • Danny Williams

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 453 • No: 90

Senate vote • 5/29/2025

OVERRIDE

Yes: 36 • No: 9

House vote • 5/29/2025

OVERRIDE

Yes: 76 • No: 12

House vote • 5/22/2025

FOURTH READING

Yes: 68 • No: 21

Senate vote • 5/22/2025

FOURTH READING

Yes: 27 • No: 15

Senate vote • 5/22/2025

EMERGENCY

Yes: 39 • No: 3

Senate vote • 5/8/2025

THIRD READING

Yes: 33 • No: 13

Senate vote • 5/8/2025

EMERGENCY

Yes: 45 • No: 1

Senate vote • 4/23/2025

Committee vote: Appropriations

Yes: 20 • No: 2

Senate vote • 4/7/2025

Committee vote: Health & Human Services

Yes: 11 • No: 0

House vote • 3/3/2025

THIRD READING

Yes: 83 • No: 14

House vote • 2/26/2025

DO PASS

Yes: 10 • No: 0

House vote • 2/5/2025

DO PASS

Yes: 5 • No: 0

Actions Timeline

  1. To Senate

    5/30/2025House
  2. Veto overridden: Ayes: 76 Nays: 12

    5/30/2025House
  3. Filed with Secretary of State

    5/29/2025House
  4. Measure returned to House

    5/29/2025Senate
  5. Veto overridden: Ayes: 36 Nays: 9

    5/29/2025Senate
  6. Vetoed 05/28/2025

    5/28/2025House
  7. Sent to Governor

    5/22/2025House
  8. Enrolled measure signed, returned to House

    5/22/2025Senate
  9. Enrolled, signed, to Senate

    5/22/2025House
  10. Referred for enrollment

    5/22/2025House
  11. Emergency passed, to House: Ayes: 39 Nays: 3

    5/22/2025Senate
  12. Measure passed, to House: Ayes: 27 Nays: 15

    5/22/2025Senate
  13. CCR adopted, GCCA

    5/22/2025Senate
  14. CCR read, GCCA

    5/22/2025Senate
  15. To Senate

    5/22/2025House
  16. Fourth Reading, Measure and Emergency Passed: Ayes: 68 Nays: 21

    5/22/2025House
  17. CCR adopted

    5/22/2025House
  18. Enacting clause restored

    5/21/2025House
  19. Title restored

    5/21/2025House
  20. Coauthored by Representative(s) Cantrell, Williams

    5/21/2025House
  21. CCR submitted

    5/21/2025House
  22. Conference granted, GCCA

    5/15/2025Senate
  23. HC's named: Conference Committee on Health and Human Services Oversight

    5/15/2025House
  24. SA's rejected, conference requested, conferees to be named later

    5/14/2025House
  25. SA's received

    5/12/2025House

Bill Text

  • Enrolled (final version)

    5/22/2025

  • House Conference Committee Report

    5/22/2025

  • Scheduled House CCR 1(A)

    5/21/2025

  • Scheduled House CCR 1(A)

    5/20/2025

  • Amended And Engrossed

    5/12/2025

  • Floor (Senate)

    4/24/2025

  • Senate Committee Report 2

    4/23/2025

  • Senate Committee Report 1

    4/7/2025

  • Engrossed

    3/4/2025

  • Floor (House)

    2/27/2025

  • House Committee Report

    2/26/2025

  • House Policy Committee Report

    2/5/2025

  • Introduced

    1/16/2025

Related Bills

Back to State Legislation